These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 23527108)

  • 1. Identification and characterization of potential therapeutic candidates in emerging human pathogen Mycobacterium abscessus: a novel hierarchical in silico approach.
    Shanmugham B; Pan A
    PLoS One; 2013; 8(3):e59126. PubMed ID: 23527108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparative Genomics Approach for Shortlisting Broad-Spectrum Drug Targets in Nontuberculous Mycobacteria.
    Swain A; Gnanasekar P; Prava J; Rajeev AC; Kesarwani P; Lahiri C; Pan A
    Microb Drug Resist; 2021 Feb; 27(2):212-226. PubMed ID: 32936741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico Drug Target Discovery Through Proteome Mining from M. tuberculosis: An Insight into Antivirulent Therapy.
    Bhattacharya S; Ghosh P; Banerjee D; Banerjee A; Ray S
    Comb Chem High Throughput Screen; 2020; 23(3):253-268. PubMed ID: 32072892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium abscessus Complex - a Particular Challenge in the Setting of Lung Transplantation.
    Smibert O; Snell GI; Bills H; Westall GP; Morrissey CO
    Expert Rev Anti Infect Ther; 2016; 14(3):325-33. PubMed ID: 26732819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report.
    Kim SY; Shin SJ; Jeong BH; Koh WJ
    BMC Infect Dis; 2016 May; 16():207. PubMed ID: 27188784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing disulfiram to target infections caused by non-tuberculous mycobacteria.
    Das S; Garg T; Chopra S; Dasgupta A
    J Antimicrob Chemother; 2019 May; 74(5):1317-1322. PubMed ID: 30753528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic resistance in
    Jayasingam SD; Zin T; Ngeow YF
    Int J Mycobacteriol; 2017; 6(4):387-390. PubMed ID: 29171453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogen Box screening for hit identification against Mycobacterium abscessus.
    Jeong J; Kim G; Moon C; Kim HJ; Kim TH; Jang J
    PLoS One; 2018; 13(4):e0195595. PubMed ID: 29698397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the management of pulmonary disease due to Mycobacterium abscessus complex.
    Koh WJ; Stout JE; Yew WW
    Int J Tuberc Lung Dis; 2014 Oct; 18(10):1141-8. PubMed ID: 25216826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug susceptibility patterns of rapidly growing mycobacteria isolated from skin and soft tissue infections in Venezuela.
    Da Mata-Jardín O; Angulo A; Rodríguez M; Fernández-Figueiras S; de Waard JH
    Eur J Clin Microbiol Infect Dis; 2020 Mar; 39(3):433-441. PubMed ID: 31741101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates.
    Lee MR; Cheng A; Lee YC; Yang CY; Lai CC; Huang YT; Ho CC; Wang HC; Yu CJ; Hsueh PR
    J Antimicrob Chemother; 2012 Jan; 67(1):222-5. PubMed ID: 21980068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. targetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis.
    Raman K; Yeturu K; Chandra N
    BMC Syst Biol; 2008 Dec; 2():109. PubMed ID: 19099550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Non-Tuberculosis Mycobacteria by Line Probe Assay and Determination of Drug Resistance Patterns of Isolates in Iranian Patients.
    Karami-Zarandi M; Bahador A; Gizaw Feysia S; Kardan-Yamchi J; Hasan-Nejad M; Mosavari N; Feizabadi MM
    Arch Razi Inst; 2019 Dec; 74(4):375-384. PubMed ID: 31939254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus.
    Abdalla MY; Switzer BL; Goss CH; Aitken ML; Singh PK; Britigan BE
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4826-34. PubMed ID: 26033732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus.
    Johansen MD; Herrmann JL; Kremer L
    Nat Rev Microbiol; 2020 Jul; 18(7):392-407. PubMed ID: 32086501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial Infections.
    Sethiya JP; Sowards MA; Jackson M; North EJ
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Complex.
    Rubio M; March F; Garrigó M; Moreno C; Español M; Coll P
    PLoS One; 2015; 10(10):e0140166. PubMed ID: 26448181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of rapidly growing mycobacterial infections.
    Kasperbauer SH; De Groote MA
    Clin Chest Med; 2015 Mar; 36(1):67-78. PubMed ID: 25676520
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.